IL6 and Alzheimer disease: Since the 1990s, increased expression of inflammatory markers—including acute phase proteins such as α1-antichymotrypsin and proinflammatory cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), and TNF-α—has been implicated in AD pathogenesis [80,81,82,83].